Pharmacoutilization and adherence to sacubitril/valsartan in real world: the REAL.IT study in HFrEF.
Massimo IacovielloGabriele Di GesaroFilippo Maria SarulloDaniela MianiMauro DriussiMichele CorrealeClaudio BilatoAndrea PassantinoErberto CarluccioAlessandra VillaniLuca Degli EspostiChiara d'AgostinoElena PeruzziSimone PoliAndrea di LenardaPublished in: ESC heart failure (2023)
Real-world data on the use of sacubitril/valsartan in clinical practice in Italy show a rapid titration to the target dose, high therapeutic adherence enabling a good level of therapeutic management in line with ESC guidelines for patients with reduced ejection fraction.